Evidence mapPaperPMID 38743805Full record

GuidelineCirculation2024

2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Heather L Gornik, Herbert D Aronow, Philip P Goodney, Shipra Arya, Luke Packard Brewster, Lori Byrd, Venita Chandra, Douglas E Drachman, Jennifer M Eaves, Jonathan K Ehrman and 21 more

Erratum issued 5 registry-linked trialsAbstract readPractice GuidelineReview
In one paragraph

Guideline in Circulation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to 5 registered trials, which are not on this map. Cited by 240 papers, 10 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
240citing papers in PubMed, 10 pooled it
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06964685 recruitingnot on this mapstarted 2025, after this paper: background citation

Observational Assessment of Support With Impella® Best Practices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Typeobservational_patient_registrySponsorAbiomed Inc.Ran2025 to 2028Enrolled350ConditionsAMI Cardiogenic ShockArmsImpella
NCT07076082 phase4recruitingnot on this mapstarted 2025, after this paper: background citation

Vascular Trial Associated Registry Pilot: Antiplatelet Therapies for Patients Undergoing Lower Extremity Endovascular Revascularization

TypeinterventionalSponsorCorewell Health WestRan2025 to 2028Enrolled350ConditionsPeripheral Arterial DiseaseArmsClopidogrel (Plavix) Pharmacogenetic Test Reagents
NCT07550959 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Evaluation of the Effectiveness of Hybrid Cardiac Rehabilitation in Peripheral Artery Disease

TypeinterventionalSponsorBiruni UniversityRan2026 to 2027Enrolled40ConditionsPeripheral Arterial DiseaseArmsHybrid Cardiac Rehabilitation, Supervised Exercise Therapy
NCT07562932 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Assessing Catecholamine Treatment Initiation Options: Norepinephrine vs Dopamine for Cardiogenic Shock

TypeinterventionalSponsorChonnam National University HospitalRan2026 to 2032Enrolled512ConditionsCardiogenic ShockArmsNorepinephrine, Dopamine Agent
NCT07655206 narecruitingnot on this mapstarted 2026, after this paper: background citation

Effectiveness of a Home-based Cardiovascular Rehabilitation Program Compared With Standard Care in Patients With Moderate to Severe Peripheral Artery Disease: a Pilot Randomized Controlled Trial (PILOT-PAD-CYCLE)

TypeinterventionalSponsorLaval UniversityRan2026 to 2027Enrolled12ConditionsPeripheral Artery DiseaseArmsHome-Based Exercise Therapy Using Portable Pedal Exerciser
3 · Its place in the literature

Who cites it

240 citing papers in PubMed, 10 syntheses or guidelines pooled it.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Guideline
  6. Pooled it
  7. Guideline
  8. Pooled it
  9. Methods to assess atherosclerotic cardiovascular risk in chronic respiratory diseases: a systematic review.European respiratory review : an official journal of the European Respiratory Society · 2025
    Pooled it
  10. Pooled it
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

180 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

31 authors.

Heather L Gornik
Herbert D Aronow
Philip P Goodney
Shipra Arya
Luke Packard BrewsterVESS representative.
Lori ByrdLayperson or patient representative.
Venita ChandraSVS representative.
Douglas E Drachman
Jennifer M Eaves
Jonathan K EhrmanAACVPR representative.
John N EvansAPMA representative.
Thomas S D Getchius
J Antonio Gutiérrez
Beau M Hawkins
Connie N Hess
Karen J Ho
W Schuyler JonesAHA/ACC Joint Committee on Clinical Practice Guidelines liaison.
Esther S H KimSVM representative.
Scott Kinlay
Lee KirkseyABC representative.
Debra Kohlman-Trigoboff
Chandler A Long
Amy West Pollak
Saher S Sabri
Lawrence B SadwinLayperson or patient representative.
Eric A Secemsky
Maya Serhal
Mehdi H ShishehborSCAI representative.
Diane Treat-JacobsonSVN representative.
Luke R WilkinsSIR representative.
Peer Review Committee Members

Funding

CSRD VA I01 CX002366NHLBI NIH HHS K23 HL150290NHLBI NIH HHS R01 HL143348
6 · The paper itself

Abstract

aimThe "2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease" provides recommendations to guide clinicians in the treatment of patients with lower extremity peripheral artery disease across its multiple clinical presentation subsets (ie, asymptomatic, chronic symptomatic, chronic limb-threatening ischemia, and acute limb ischemia).

methodsA comprehensive literature search was conducted from October 2020 to June 2022, encompassing studies, reviews, and other evidence conducted on human subjects that was published in English from PubMed, EMBASE, the Cochrane Library, CINHL Complete, and other selected databases relevant to this guideline. Additional relevant studies, published through May 2023 during the peer review process, were also considered by the writing committee and added to the evidence tables where appropriate. STRUCTURE: Recommendations from the "2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease" have been updated with new evidence to guide clinicians. In addition, new recommendations addressing comprehensive care for patients with peripheral artery disease have been developed.

Indexed as

American Heart AssociationLower ExtremityPeripheral Arterial DiseaseCardiologyHumansUnited Statesacute limb ischemiaAHA Scientific Statementsangioplastyankle-brachial indexanticoagulation therapyantiplatelet therapyantithrombotic therapyatherosclerosisatypical leg symptomsblood pressure loweringbypass graft/bypass grafting/surgical bypasscilostazolclaudication/intermittent claudicationcritical limb ischemia/chronic limb-threatening ischemiadiabetesdiagnostic testingendovascular therapyexercise rehabilitation/exercise therapy/exercise training/supervised exercisefoot carehybrid approach, lipid lowering, lower extremity/foot wound/ulcermedical managementopen revascularizationpercutaneous therapyperipheral artery disease/peripheral arterial disease/peripheral vascular disease/lower extremity arterial diseasesmoking/smoking cessationstatinstentingthrombolysisvascular interventionvascular surgery

Identifiers

PMID38743805
PMCPMC12782132

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.